অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

reckitt benckiser pty ltd - sodium bicarbonate, quantity: 106.5 mg; sodium alginate, quantity: 250 mg; calcium carbonate, quantity: 187.5 mg - tablet, chewable - excipient ingredients: aspartame; copovidone; magnesium stearate; xylitol; carmoisine aluminium lake; acesulfame potassium; mannitol; macrogol 20000; carmellose sodium; flavour - relief of the symptoms associated with reflux oesophagitis, hiatus hernia and all cases of epigastric distress where the underlying cause is gastro-oesophageal reflux. fast, soothing relief of heartburn and acid indigestion due to gastro-oesophageal reflux.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

reckitt benckiser pty ltd - sodium alginate, quantity: 50 mg/ml; calcium carbonate, quantity: 32.5 mg/ml; sodium bicarbonate, quantity: 21.3 mg/ml - oral liquid, suspension - excipient ingredients: propyl hydroxybenzoate; purified water; sodium hydroxide; methyl hydroxybenzoate; carbomer homopolymer (type b); saccharin sodium; flavour - fast, soothing, long lasting relief from heartburn and acid indigestion.

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

northwind pharmaceuticals - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 50 mg - carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets, usp and other treatment options before deciding to use diclofenac sodium delayed-release. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). diclofenac sodium delayed-release tablets are indicated: • for relief of the signs and symptoms of osteoarthritis • for relief of the signs and symptoms of rheumatoid arthritis • for acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis diclofenac sodium delayed-release tablets, usp are contraindicated in patients with known hypersensitivity to diclofenac. diclofenac sodium delayed-release should not be given to patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions, and precau

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

reckitt benckiser pty ltd - sodium bicarbonate, quantity: 26.7 mg/ml; sodium alginate, quantity: 50 mg/ml; calcium carbonate, quantity: 16 mg/ml - oral liquid - excipient ingredients: saccharin sodium; purified water; methyl hydroxybenzoate; carbomer homopolymer (type b); propyl hydroxybenzoate; sodium hydroxide; flavour - fast, soothing, long lasting relief from heartburn and acid indigestion.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

reckitt benckiser pty ltd - sodium alginate, quantity: 250 mg; sodium bicarbonate, quantity: 106.5 mg; calcium carbonate, quantity: 187.5 mg - tablet, chewable - excipient ingredients: magnesium stearate; carmellose sodium; aspartame; macrogol 20000; acesulfame potassium; copovidone; xylitol; carmoisine aluminium lake; mannitol; flavour - relief of the symptoms associated with reflux oesophagitis, hiatus hernia and all cases of epigastric distress where the underlying cause is gastro-oesophageal reflux. fast, soothing relief of heartburn and acid indigestion due to gastro-oesophageal reflux.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

reckitt benckiser pty ltd - sodium bicarbonate, quantity: 26.7 mg/ml; sodium alginate, quantity: 50 mg/ml; calcium carbonate, quantity: 16 mg/ml - oral liquid, suspension - excipient ingredients: purified water; saccharin sodium; sodium hydroxide; propyl hydroxybenzoate; methyl hydroxybenzoate; carbomer 934p; flavour - fast, soothing, long lasting relief from heartburn and acid indigestion.

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - magnesium trisilicate; sodium alginate; sodium bicarbonate; aluminium hydroxide gel dried - oral suspension - 8mg/1ml ; 44mg/1ml ; 14mg/1ml ; 16mg/1ml

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

blenheim pharmacal, inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets, usp and other treatment options before deciding to use diclofenac sodium delayed-release tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). diclofenac sodium delayed-release tablets are indicated: - for relief of the signs and symptoms of osteoarthritis - for relief of the signs and symptoms of rheumatoid arthritis - for acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis diclofenac sodium delayed-release tablets, usp are contraindicated in patients with known hypersensitivity to diclofenac. diclofenac sodium delayed-release should not be given to patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reaction

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets, usp and other treatment options before deciding to use diclofenac sodium delayed-release tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). diclofenac sodium delayed-release tablets are indicated: - for relief of the signs and symptoms of osteoarthritis - for relief of the signs and symptoms of rheumatoid arthritis - for acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis diclofenac sodium delayed-release tablets, usp are contraindicated in patients with known hypersensitivity to diclofenac. diclofenac sodium delayed-release should not be given to patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnin

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets, usp and other treatment options before deciding to use diclofenac sodium delayed-release tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). diclofenac sodium delayed-release tablets are indicated: - for relief of the signs and symptoms of osteoarthritis - for relief of the signs and symptoms of rheumatoid arthritis - for acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis diclofenac sodium delayed-release tablets, usp are contraindicated in patients with known hypersensitivity to diclofenac. diclofenac sodium delayed-release should not be given to patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reaction